Silver Spring, Maryland, United States United Therapeutics appeared to be the Corporate Investor, which was created in 1996. The leading representative office of defined Corporate Investor is situated in the Silver Spring. The fund was located in North America if to be more exact in United States.
This organization was formed by Martine Rothblatt.
Among the most popular portfolio startups of the fund, we may highlight Celularity, Transoma Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Wireless, Health Care.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the United Therapeutics, startups are often financed by Polaris Partners, Canaan Partners, Affinity Capital Management. The meaningful sponsors for the fund in investment in the same round are Tony Robbins, Sorrento Therapeutics, Section 32. In the next rounds fund is usually obtained by National Institutes of Health, American Heart Association.
The top activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| Acero Capital | California, Menlo Park, United States |
| Bond Capital | British Columbia, Canada, Vancouver |
| Carrot | - |
| Engagement Commerce Lab | Japan, Tokyo |
| Investec | Cape Town, South Africa, Western Cape |
| Salt Ventures | - |
| Southpoint Capital Advisors | New York, New York, United States |
| Sponsor Capital | Finland, Helsinki, Southern Finland |
| WellSpan Health | Pennsylvania, United States, York |
| Xizang Jiuling Chuangye Touzi | Chengguan District, China, Lhasa |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 